Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils

Journal of Experimental Medicine

Volumn 188, Issue 6, 1998, Pages 1063-1074

  Huang, Wei Wei ^a   Garcia Zepeda, Eduardo A ^a   Sauty, Alain ^a   Oettgen, Hans C ^b   Rothenberg, Marc E ^c   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Asthma; Chemotactic factor; Eosinophil; G protein coupled receptor; Leukotriene B4

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOTRIENE B4 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL INFILTRATION; EOSINOPHIL; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL LINE; CHEMOTACTIC FACTORS, EOSINOPHIL; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; EOSINOPHILS; FEMALE; HUMANS; LEUKOTRIENE B4; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PLASMIDS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RECEPTORS, LEUKOTRIENE B4; RESPIRATORY HYPERSENSITIVITY; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032555952     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.6.1063     Document Type: Article

References (70)

1. Weller, P.F. 1991. The immunobiology of eosinophils. N. Eng. J. Med. 324:1110-1118.
2. Bousquett, J., P. Chanez, J.Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, et al. 1990. Eosinophilic inflammation in asthma. N. Eng. J. Med. 323:1033-1039.
3. Bochner, D.S., and R.P. Schleimer. 1994. The role of adhesion molecules in human eosinophil and basophil recruitment J. Allergy Clin. Immunol. 94:427-428.
4. Resnick, M.B., and P.F. Weller. 1993. Mechanisms of eosinophil recruitment. Am. J. Respir. Cell. Mol. Biol. 8:349-355.
5. Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today. 15:127-133.
6. Kitayama, J., M. W. Carr, S.J. Roth, J. Buccola, and T.A. Springer. 1997. Contrasting responses to multiple chemotactic stimuli in transendothelial migration. J. Immunol. 158:2340-2349.
7. Luster, A.D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Eng. J. Med. 388:436-445.
8. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
9. Kita, H., and G.J. Gleich. 1996. Chemokines active on eosinophils: potential roles in allergic inflammation. J. Exp. Med. 183:2421-2426.
10. Garcia-Zepeda, E.A., M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder, and A.D. Luster. 1996. Human eotaxin is specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 4:449-456.
11. Garcia-Zepeda, E.A., C. Combardiere, M.E. Rothenberg, M. Sarafi, Q. Hamid, P.M. Murphy, and A.D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4: a novel CC chemokine with activities on monocytes, eosinophils, and basophils, induced in allergic and non-allergic inflammation, that signals through the CC chemokine receptors CCR-2 and CCR-3. J. Immunol. 157:5613-5626.
12. Forrsmann, U., M. Uguccioni, P. Loetscher, C.A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp. Med. 185:2171-2176.
13. Schweizer, R.C., J.A.M. Welmer, P. Raaijmakers, J. Zanen, W.J. Lammers, and L. Koenderman. 1994. RANTES- and interleukin-8-induced responses in normal eosinophils: effects of priming with interleukin-5. Blood. 83:3697-3704.
14. Wardlaw, A.J., R. Moqbel, O. Cromwell, and A.B. Kay. 1986. Platelet-activating factor: a potent chemotactic and chemokinetic factor tor human eosinophils. J. Clin. Invest. 78:1701-1706.
15. Morita, E., J.-M. Schroder, and E. Christophers. 1989. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand.J. Immunol. 29:709-716.
16. 4 receptor. J. Immunol. 147:3096-3103.
17. Sun, F.F., N.J. Crittenden, C.I. Czuk, B.M. Taylor, B.K. Stout, and H.G. Johnson. 1991. Biochemical and functional differences between eosinophils from animal species and man. J. Leuk. Biol. 50:140-150.
18. Rothenberg, M.E., A.D. Luster, C.M. Lilly, J.M. Drazen, and P. Leder. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 181:1211-1216.
19. Gerard, N.P., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature. 349:614-617.
20. Honda, Z.-I., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama, H. Okado, H. Tok, K. Ito, T. Miyamato, and T. Shimizu. 1991. Cloning and functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349:342-346.
21. Ye, R.D., S.L. Cavanagh, O. Quehenberger, E.R. Prossnitz, and C.G. Cochrane. 1992. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184:582-589.
22. 4 Receptor. J. Exp. Med. 180:253-260.
23. Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
24. Gerard, N.P., M.K. Hodges, J.M. Drazen, P.F. Weller, and C. Gerard. 1989. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J. Biol. Chem. 264:1760-1766.
25. Elsner, J., M. Oppermann, and A. Kapp. 1996. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies. Eur. J. Immunol. 26:1560-1564.
26. Post, T.W., C.R. Bozic, M.E. Rothenberg, A.D. Luster, N. Gerard, and C. Gerard. 1995. Molecular cloning of two murine eosinophil beta chemokine receptors. J. Immunol. 155: 5299-5305.
27. Gao, J.-L., A.I. Sen, L. Tiffany, O. Yoshi, M.E. Rothenberg, P.M. Murphy, and A.D. Luster. 1996. Identification of a mouse eosinophil-selective receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. 223:679-684.
28. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, P.D. Ponath, and C.R. Mackay. 1997. Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-184.
29. Akbar, G., V. Dasari, T. Webb, K. Ayyanathan, K. Pillarisetti, A. Sandhu, R. Athwal, J. Daniel, B. Ashby, E. Barnard, and S. Kunapuli. 1996. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J. Biol. Chem. 271:18363-18367.
30. 4 that mediate chemotaxis. Nature. 387:620-624.
31. Alexander, S.P.H., and J.A. Peters. 1997. Receptors and ion channel nomenclature. Trends Pharmacol. Sci. 45(Suppl.):50-51.
32. Dent, L.A., M. Strath, A.L. Mellor, and C.J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172:1425-1431.
33. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in IL-4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.
34. Luo, Y., J. Laning, S. Devi, J. Mak, T.J. Schall, and M.E. Dorf. 1994. Biologic activities of the murine β-chemokine TCA-3. J. Immunol. 153:4616-4624.
35. Elson, A., C. Deng, J. Campos-Torres, L.A. Donehower, and P. Leder. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene. 11:181-190.
36. Shen, M.M., and P. Leder. 1992. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc. Natl. Acad. Sci. USA. 89:8240-8244.
37. Rich, B.E., and J.A. Steitz. 1987. Human acidic ribosomal phosphoproteins P0, P1, and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Mol. Cell. Biol. 7:4065-474.
38. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 10.32-10.33.
39. 2Y purinoceptor. Eur. J. Pharm. 291:281-289.
40. Owman, C., C. Nilsson, and S.J. Lolait. 1996. Cloning of cDNA encoding a putative chemoattractant receptor. Genomics. 37:187-194.
41. Raport, C.J., V.L. Schweickart, D. Chantry, R.L. Eddy, T.B. Shows, R. Godiska, and P.W. Gray. 1996. New members of the chemokine receptor gene family. J. Leuk. Biol. 59:18-23.
42. Mehlhop, P.D., M. van de Rijn, A.B. Goldberg, J.P. Brewer, V.P. Kurup, T.R. Martin, and H.C. Oettgen. 1997. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. USA. 94:1344-1349.
43. Samuelsson, B., S.-E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176.
44. Lewis, R.A., K.F. Austen, and R.J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. N. Eng. J. Med. 323:645-655.
45. Henderson, W.R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697.
46. 4 pathway to inflammation control. Nature. 384:39-43.
47. 4 to receptors on human polymorphonuclear leukocytes. J. Immunol. 129:1600-1604.
48. 4 binding to human neutrophils. Prostaglandins. 28:837-849.
49. Bomalaski, J.S., and S. Mong. 1987. Binding of leukotriene B4 and its analogs to human polymorphonuclear leukocyte membrane receptors. Prostaglandins. 33:855-867.
50. 4 is the functional ligand binding to and activating the cloned chemoattractant receptor, CMKRL1. Biochem. Biophys. Res. Commun. 240:162-166.
51. 7. Biochem. Biophys. Res. Commun. 235:717-721.
52. Ford-Hutchinson, A.W., M.A. Bray, M.V. Doig, M.E. Shipley, and M. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 286:264-265.
53. 4 enhances interleukin 6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood. 80:1004-1011.
54. Demitsu, T., H. Katayama, T. Saito-Taki, H. Yaoita, and M. Nakano. 1989. Phagocytosis and bactericidal action of mouse peritoneal macrophages treated with leukotriene B4. Int. J. Immunopharmacol. 11:801-808.
55. Bailie, M.B., T.J. Standiford, L.L. Laichalk, M.J. Coffey, R. Stricter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157:5221-5224.
56. Stankova, J., N. Gagnon, and M. Rola-Pleszczynski. 1992. Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes. Immunol. 76:258-263.
57. 4 in human lymphocyte cultures. Prostaglandins Leukot. Med. 23:207-210.
58. 4 augments human natural cytotoxic cell activity. Biochem. Biophys. Res. Commun. 113:531-537.
59. 111Ineosinophils induced by inflammatory mediators, in vivo. Immunol. 73:222-227.
60. Teixeira, M.M., T.N.C. Wells, N.W. Lukacs, A.E.I. Proudfoot, S.L. Kunkel, T.J. Williams, and P.G. Hellewell. 1997. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657-1666.
61. Sehmi, R., A.J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A.B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response to eosinophils obtained from normal but not eosinophilic subjects. Blood. 79:2952-2959.
62. Richards, I.M., R.L. Griffin, J.A. Oostveen, J. Morris, D.G. Wishka, and C.J. Dunn. 1989. Effect of the selective leukotriene B4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Am. Rev. Respir. Dis. 140:1712-1716.
63. Gladue, R., L. Carroll, A. Milici, D. Scampoli, H. Stukenbrok, E. Pettipher, E. Salter, S. Contillo, and H. Showell. 1996. Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J. Exp. Med. 183:1893-1898.
64. Henderson, W.R., D.B. Lewis, R.K. Albert, Y. Zhang, W.J.E. Lamm, G.K.S. Chiang, F. Jones, P. Eriksen, Y. Tien, M. Jonas, and E.Y. Chi. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483-1494.
65. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am. Rev. Respir. Dis. 142:112-119.
66. Wenzel, S.E., J.Y. Westcott, and G.L. Larson. 1991. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late phase responses. J Allergy Clin. Immunol. 87:540-548.
67. Wenzel, S.E., J.B. Trudeau, D.A. Kaminsky, J. Cohn, R.J. Martin, and J.Y. Westcott. 1995. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:897-905.
68. Israel, E., R. Dermarkarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J.M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Eng. J. Med. 323:1740-1744.
69. Israel, E., P. Rubin, J.P. Kemp, J. Grossman, W. Pierson, S.C. Siegel, D. Tinkelman, J.J. Murray, W. Busse, A.T. Segal, et al. 1993. The effects of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Intern. Med. 119:1059-1066.
70. Liu, M.C., L.M. Dube, J. Lancaster, and Z.S. Group. 1996. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. J. Allergy Clin. Immunol. 98:859-871.